Svai Sanford

On May 8 join DEIB leaders from MassBio, California Life Sciences (CLS), Eli Lilly and Company and Takeda as we explore changing attitudes in the life sciences workforce, if organizations are adjusting either their DEIB or communication strategies, and how evolving philosophies around DEIB are impacting human resources and talent acquisition activities. Register below! #diversity #lifesciences #insights #biospace https://hubs.li/Q02vXs3n0

10

Dive into our latest blog, where Kyle Felmet and Riparian LLC's Jennifer Lospinoso discuss transformative strategies and key considerations that are shaping the commercialization of cell and gene therapies (CGT). Their analysis covers the rapid advancements in CGT, the strategic planning required for successful market entry, and the innovative distribution models that ensure these groundbreaking treatments reach patients effectively. https://bit.ly/4boUaQl

56

1 Comment

📢 Entos Pharmaceuticals Opens State-of-the-Art GMP Facility 📢 Entos Pharmaceuticals has opened a GMP facility in Carlsbad, CA to support IND-enabling studies and clinical trials. 🔬 The facility is 20,000 square feet and will help Entos advance its pipeline of 20 programs. 💰 The cost of the facility has not been disclosed, but it has room for expansion. 🌎 Entos also plans to build a commercial manufacturing facility in Alberta, Canada, as part of its global manufacturing strategy. #BioprocessUpdates #EntosPharmaceuticals #GMPfacility #manufacturing #clinicaltrials #INDenablingstudies #pharmaceuticalindustry #CarlsbadCA #pipeline #expansion #globalmanufacturing #AlbertaCanada #commercialmanufacturing #biotech #pharmaceuticals #medicalresearch ▷ Read the full article here: 📎 https://lnkd.in/dE4eRN7n

36

9 Top Biopharma CEO-to-Employee Pay Gaps Last year, empowered by new SEC reporting guidelines, BioSpace released its inaugural annual CEO pay gap report, looking at how much more top biopharma executives earned than their employees in 2022. Results showed that many biopharma executives earn more than 200 times what the company’s median employee makes Click the below link to give it a full read. Vibrant99 Solutions BioSpace #Information #Updates #News #Info #Vibrant99 #Biospace

5

🎉 Get ready to unlock the keys to success in the small biopharma sector with Jerry W., Associate Director at Ascentage Pharma, LIVE at the 20th Biopharma Clinical Trials Nexus Conference! 🌟 Join Jerry as he delves into the dynamic world of "Effectively Steering Your Clinical Trials for Success in the Small Biopharma Sector." 🚀🔬 Dive deep into actionable strategies, insider tips, and real-world case studies tailored specifically for small biopharma innovators. 💡 Don't miss this exclusive opportunity to learn from one of the industry's brightest minds and gain the competitive edge you need to drive your clinical trials to success. 🎤 #BiopharmaClinicalTrials #Innovation #SuccessSecrets #SanDiegoConference

27

1 Comment

If you're curious how Theragent can support your cell therapy development, check out Brian Newsom's presentation on our latest capabilities and capacities. Thank you to Outsourced Pharma for hosting a great session! If you have any questions, send us a message to learn more about how Theragent can partner on your cell therapy at any stage. #CDMO #CGT #Manufacturing

16

Hear from Tim Tyson, Chairman and CEO of TriRx Pharmaceutical Services, LLC, in our Pharma's Almanac roundtable. Experts from across life sciences answered the following prompt: Environmental, social, and governance (ESG) criteria are becoming more important to investors and stakeholders. How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing? Read Tim's full response, and hear from many other thought leaders, in the full article linked here: https://lnkd.in/dq9CxpE8 #ESG #pharma #pharmaceuticalmanufacturing #paroundtable

12

In this interview-style article by Meg Waters of Treasury & Risk, the treasury team at Bristol Myers Squibb - including Amy Szuting Chen, Sandra Ramos-Alves, CPA, and Abhishek Jhunjhunwala - elaborate on their recent award-winning projects in the area of cash and liquidity management. Congratulations again to the BMS team for all their hard work and success over the past few years, and thanks for letting us be a part of your journey! Interested parties can read the full article using the below link. https://lnkd.in/e6QgwiPE #treasury #finance #cashflow

35

1 Comment

Check out our Customer Highlight featuring Nimble Therapeutics's VP of Therapeutic Discovery, Lauren Goodrich-Berto: "Rapid access to diverse chemical space is critical for identifying peptide hits and transforming them into clinical candidates. One of the most successful strategies in peptide discovery is the incorporation of noncanonical amino acids. However, access to noncanonical amino acids has been extremely costly, even with significantly restricted chemical space. This is especially true for building blocks in the D-configuration. Aralez Bio has unlocked a vast toolbox of noncanonical amino acids, enhancing Nimble’s platform and allowing us to tune peptides in ways that were not previously feasible. Our scientists are excited to access new amino acid space for the discovery and optimization of peptide ligands. The icing on the cake is that the enzymatic process is significantly greener than “traditional” amino acid synthesis. We look forward to seeing what additional noncanonical amino acids Aralez Bio can unlock in the future." To see what's available now & coming in the future, email us at info@aralezbio.com #noncanonical #ncAA #aralezbio #customerhighlight #peptide #greenchemistry #sustainability

14

One year ago, our Chief Scientific Officer, Li Peng, was named to Endpoints News’ list of top women leading biopharma R&D – a testament to her drive and dedication to develop glycan editing, an entirely new field of drug development. Li has played a major role in the Palleon story and how our science came to be, developing an enzyme-based approach to editing cell-surface sugars. In case you missed it, view the list of honorees here: https://bit.ly/3OmW1gj #glycotime

135

14 Comments

Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering. BURLINGAME, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS) (GLOBAL NEWSWIRE), a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with new and existing investors to raise approximately $30.6 million dollars in aggregate gross proceeds through the sale of shares of its common stock, par value $0.0001 per share (the “Common Stock”) and pre-funded warrants to purchase Common Stock in lieu thereof (the “Pre-Funded Warrants”), and accompanying common warrants to purchase Common Stock (or Pre-Funded warrants in lieu thereof) (the “Common Warrants,” and together with the Common Stock and Pre-Funded Warrants, the “Securities”), excluding the proceeds, if any, from the exercise of the Pre-Funded Warrants and the Common Warrants and before deducting offering expenses. The offering includes participation from health-care dedicated investors including Point72, Samlyn Capital, Armistice Capital, OrbiMed, Puissance Capital and Altamont Pharmaceutical Holdings, and other existing investors including Richard Miller, the Company’s chief executive officer. https://lnkd.in/gGq7atBE

13

Slone Partners CEO & Managing Partner Leslie Loveless is featured in the newest episode of “Conversations Life Sciences Leaders Aren’t Having,” a podcast hosted by Jeff Harmon. This is an insightful and lively conversation touching on a range of topics including the power of partnerships, her strategies on leadership, the transformative power of #workplaceculture, and the joys of raising an adopted child. Take a listen and share your thoughts below! #lifesciences #healthcare #executivesearch

41

2 Comments

Taking the solutions from the stage to the boardroom is Tim Hughes, Sr. Director at Merck. He sits down with Komodo CEO Arif Nathoo for a discussion on the power #RWE, #analytics, and #AI can have on revolutionizing #LifeSciences. #KomodoSummit.

36

3 Comments

🌟 We're thrilled to spotlight our prestigious Pantheon Biopharma Award, honoring innovation and excellence in the biopharmaceutical industry. Presented to a biotech or pharmaceutical company that has made groundbreaking advancement and contribution to the California life sciences sector in the prior year. 🧬 Award Criteria: Our rigorous selection process evaluates key factors such as product launch, scientific breakthrough, facility openings, employee growth, or partnering deals/acquisitions that will foster future advancements for the industry. 🏆 Past Winners: Previous awardees have made significant contributions to biopharma development, demonstrating leadership and transformative impact in the field. Past distinguished winners include: BioMarin Pharmaceutical Inc. (2023) and Coherus BioSciences (2022). 🔗 Learn more about the award and our methodology: https://bit.ly/4fjq1Fx Join us in celebrating those who push the boundaries of science and healthcare! #Biopharma #Innovation #CaliforniaLifeSciences #Pantheon

14

Japan's pharmaceutical market is booming, fueled by an aging population and progressive Regulatory changes. Explore new opportunities with Freyr Solutions and our team of elite professionals in Japan, facilitating seamless market entry and Regulatory compliance. Contact Freyr Solutions! https://lnkd.in/gGdj2-xe #Japan #PharmaceuticalMarket #RegulatoryCompliance #MarketEntry #FreyrSolutions

3